IHH Healthcare Berhad
IHH Healthcare Berhad Fundamental Analysis
IHH Healthcare Berhad (IHHHF) shows moderate financial fundamentals with a PE ratio of 24.69, profit margin of 8.16%, and ROE of 6.92%. The company generates $25.7B in annual revenue with strong year-over-year growth of 16.47%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 47.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze IHHHF's fundamental strength across five key dimensions:
Efficiency Score
WeakIHHHF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentIHHHF trades at attractive valuation levels.
Growth Score
ModerateIHHHF shows steady but slowing expansion.
Financial Health Score
ModerateIHHHF shows balanced financial health with some risks.
Profitability Score
WeakIHHHF struggles to sustain strong margins.
Key Financial Metrics
Is IHHHF Expensive or Cheap?
P/E Ratio
IHHHF trades at 24.69 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, IHHHF's PEG of -0.79 indicates potential undervaluation.
Price to Book
The market values IHH Healthcare Berhad at 1.71 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.97 times EBITDA. This is generally considered low.
How Well Does IHHHF Make Money?
Net Profit Margin
For every $100 in sales, IHH Healthcare Berhad keeps $8.16 as profit after all expenses.
Operating Margin
Core operations generate 14.12 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.92 in profit for every $100 of shareholder equity.
ROA
IHH Healthcare Berhad generates $3.65 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
IHH Healthcare Berhad produces operating cash flow of $5.38B, showing steady but balanced cash generation.
Free Cash Flow
IHH Healthcare Berhad produces free cash flow of $1.81B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.20 in free cash annually.
FCF Yield
IHHHF converts 3.49% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
24.69
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.79
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.71
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.01
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.58
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.58
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.07
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
0.08
vs 25 benchmark
How IHHHF Stacks Against Its Sector Peers
| Metric | IHHHF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 24.69 | 27.91 | Better (Cheaper) |
| ROE | 6.92% | 687.00% | Weak |
| Net Margin | 8.16% | -45285.00% (disorted) | Weak |
| Debt/Equity | 0.58 | 0.33 | Weak (High Leverage) |
| Current Ratio | 0.58 | 2795.76 | Weak Liquidity |
| ROA | 3.65% | -13557.00% (disorted) | Weak |
IHHHF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews IHH Healthcare Berhad's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
62.89%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
379.84%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
74.37%
Industry Style: Defensive, Growth, Innovation
High Growth